SEC Form 4 · accession 0001140361-16-050405
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen J Sullivan
Director
Period of report
Feb 3, 2016
Accepted (ET)
Feb 5, 2016 · 1:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2016 | A | 100,000 | $0.47 | A | 197,828 | D | |
| Common Stock | holding | — | — | — | 97,828 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Sullivan was awarded 100,000 restricted stock units, of which 33,333 RSUs vest on 1/1/17, 33,333 RSUs vest on 1/1/18, and 33,334 RSUs vest on 1/1/19.